Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Wu

Showing results (421-430 of 434) with videos related to

Pageof 44
Sort By:
Journal of Medical Microbiology|February 16, 2021
Loss of the virulence plasmid by <i>Shigella sonnei</i> promotes its interactions with CD207 and CD209 receptorsBi-Cong Wu, Njiri A Olivia, John Mambwe Tembo, et al.
Nature Communications|April 22, 2026
Nasopharyngeal carcinoma screening using Epstein-Barr virus Cp methylation triage in two population-based screening cohortsZhi-Cong Wu, Xia Yu, Guang-Cong Yi, et al.
Journal of Virology|August 2, 2013
Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infectionXing Pan, Xiao-Jun Li, Xi-Juan Liu, et al.
Journal of Virology|October 30, 2016
Correction for Pan et al., Later Passages of Neural Progenitor Cells from Neonatal Brain Are More Permissive for Human Cytomegalovirus InfectionXing Pan, Xiao-Jun Li, Xi-Juan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2026
T-cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trialXiongfei Xu, Haihui Gu, Zhanshan Cha, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Translational Vision Science & Technology|October 18, 2022
Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular EdemaNicholas J Agard, Gu Zhang, John Ridgeway, et al.
Nature Communications|March 5, 2025
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patientsXiaoyi Yin, Hui Shen, Huan Wang, et al.
Chemmedchem|November 2, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo ActivityThomas H Pillow, Pragya Adhikari, Robert A Blake, et al.
Pageof 44

Showing results (421-430 of 434) with videos related to

Sort By:
Pageof 44
Journal of Medical Microbiology|February 16, 2021
Loss of the virulence plasmid by <i>Shigella sonnei</i> promotes its interactions with CD207 and CD209 receptorsBi-Cong Wu, Njiri A Olivia, John Mambwe Tembo, et al.
Nature Communications|April 22, 2026
Nasopharyngeal carcinoma screening using Epstein-Barr virus Cp methylation triage in two population-based screening cohortsZhi-Cong Wu, Xia Yu, Guang-Cong Yi, et al.
Journal of Virology|August 2, 2013
Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infectionXing Pan, Xiao-Jun Li, Xi-Juan Liu, et al.
Journal of Virology|October 30, 2016
Correction for Pan et al., Later Passages of Neural Progenitor Cells from Neonatal Brain Are More Permissive for Human Cytomegalovirus InfectionXing Pan, Xiao-Jun Li, Xi-Juan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2026
T-cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trialXiongfei Xu, Haihui Gu, Zhanshan Cha, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Translational Vision Science & Technology|October 18, 2022
Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular EdemaNicholas J Agard, Gu Zhang, John Ridgeway, et al.
Nature Communications|March 5, 2025
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patientsXiaoyi Yin, Hui Shen, Huan Wang, et al.
Chemmedchem|November 2, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo ActivityThomas H Pillow, Pragya Adhikari, Robert A Blake, et al.
Pageof 44